immunotherapy
Roche lung cancer treatments perform
May 14, 2015Sales and Marketing MPDL3280A, Roche, alectinib, immunotherapy
Roche has revealed promising trial data from two lung cancer treatments with one improving survival and the other shrinking tumours. …
Novartis signs $90m deal with Oxford BioMedica
October 10, 2014Manufacturing and Production, Research and Development, Sales and Marketing CART-019, Novartis, Oxford BioMedica, immunotherapy, oxb
UK-based biotech Oxford BioMedica is working with Novartis in a transformational deal for the firm worth $90 million to develop …
Novartis buys into Transgene’s lung cancer candidate
March 11, 2010Research and Development Novartis, Transgene, immunotherapy, lung cancer
French biotech company Transgene has signed a deal with Novartis for the future development and marketing of its potential lung …
Latest content
Five Facts about cardiovascular disease
August 9, 2026
